{"entity":{"id":"nct02864992","kind":"trial","name":"Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)","aka":[],"tldr":"A phase 2 trial of Tepotinib in non-small-cell lung cancer and small-cell lung cancer, run by EMD Serono Research & Development Institute, Inc., active and no longer recruiting.","summary":"Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) is a phase 2 interventional study registered as NCT02864992 by EMD Serono Research & Development Institute, Inc., with 337 participants enrolled, started 2016-09-13 and due to reach its primary completion in 2022-05-16. Interventions recorded: Tepotinib. Conditions listed: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT02864992","url":"https://clinicaltrials.gov/study/NCT02864992"}],"tags":["ctgov-ingest"],"related":[],"cancers":["nsclc","sclc"],"sections":[],"technologies":[],"targets":[],"drugs":["tepotinib"],"companies":["merck-kgaa"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT02864992","phase":"2","setting":"A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)","sponsor":"EMD Serono Research & Development Institute, Inc.","enrolled":337,"outcomes":[]},"route":"/trials/nct02864992/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"tepotinib","kind":"drug","name":"Tepotinib","route":"/drugs/tepotinib/"}],"company":[{"id":"merck-kgaa","kind":"company","name":"Merck KGaA (EMD Serono)","route":"/companies/merck-kgaa/"}]}}